Stock listing

CDXS Stock Price, News, Filings & Events — Codexis, Inc.

Selected listing: CDXS · BOATS · USD · US

This page tracks Codexis, Inc.'s CDXS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CDXS:BOATS. CDXS:BOATS is the stock-level entry point for investors researching Codexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Codexis, Inc. (ticker: CDXS) is a public company based in the United States with a market capitalization of approximately $134.5 million. The company focuses on developing and commercializing innovative enzyme-based solutions for various industries. Codexis aims to enhance product performance and sustainability through its advanced biotechnology platform.

CDXS:BOATSUSDUSUpdated August 28, 2026
Codexis, Inc. logo
Ticker
CDXS:BOATS
Asset type
Stock
Market cap
$174.1M
Sector
Process Industries
Industry
Chemicals: Specialty
Exchange
BOATS
Currency
USD

Codexis, Inc. CDXS:BOATS stock context

This page tracks Codexis, Inc.'s CDXS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CDXS:BOATS. CDXS:BOATS is the stock-level entry point for investors researching Codexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Codexis, Inc. (ticker: CDXS) is a public company based in the United States with a market capitalization of approximately $134.5 million. The company focuses on developing and commercializing innovative enzyme-based solutions for various industries. Codexis aims to enhance product performance and sustainability through its advanced biotechnology platform.

Latest news from Codexis, Inc.

All Codexis, Inc. news →

Codexis, Inc. earnings calls

Research Codexis, Inc.

Alternate listings